Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
High-grade serous ovarian cancer (HGSOC) remains the most lethal gynecologic cancer in the United States. Genomic analysis revealed roughly half of HGSOC display homologous repair deficiencies. An improved understanding of the genomic and somatic mutations that influence DNA repair led to the develo...
Main Authors: | Sara Bouberhan, Lauren Philp, Sarah Hill, Linah F Al-Alem, Bo Rueda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1206 |
Similar Items
-
Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
by: Renata Rodrigues da Cunha Colombo Bonadio, et al.
Published: (2018-08-01) -
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer
by: Margarita Romeo, et al.
Published: (2018-10-01) -
Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
by: Michela Camilla Milanesio, et al.
Published: (2020-05-01) -
Integration of PARP-inhibitors in ovarian cancer therapy
by: Antonella Pietragalla, et al.
Published: (2020-06-01) -
Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
by: Jenny-Maria Jönsson, et al.
Published: (2021-01-01)